GMDClass II
Antisera, Latex Agglutination, Cryptococcus Neoformans
21 CFR 866.3165 / Microbiology
GMD is the FDA product code for Antisera, Latex Agglutination, Cryptococcus Neoformans, a class II device type, regulated under 21 CFR 866.3165. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and 3 recalls.
Classification record
- Product code
- GMD
- Device name
- Antisera, Latex Agglutination, Cryptococcus Neoformans
- Regulation
- 21 CFR 866.3165
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 10
- Ingested recalls
- 3
Clearances, product code GMD
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1978 | 1 |
| 1979 | 1 |
| 1980 | 1 |
| 1981 | 2 |
| 1989 | 1 |
| 1993 | 1 |
| 1994 | 1 |
| 2011 | 1 |
| 2012 | 1 |
Applicants with the most clearances
Product code GMD| Applicant | Clearances |
|---|---|
| IMMY, Inc. | 4 |
| Meridian Diagnostics, Inc. | 2 |
| Alexon Biomedical, Inc. | 1 |
| American Scientific Products | 1 |
| I M, Inc. | 1 |
| Trinity Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
